Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pediatric dermatology

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/pde.12869PMID 27246751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Dosing Protocol on Distribution of Propranolol in Periocular Tissues after Topical Ocular Instillation

  2015cited by this paper
• Outpatient Use of Oral Propranolol and Topical Timolol for Infantile Hemangiomas: Survey Results and Comparison with Propranolol Consensus Statement Guidelines

  2015cited by this paper
• 未熟児網膜症に対する経口プロプラノロール:リスク,安全性,懸念,視点

  2013cited by this paper
• Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

  2013cited by this paper
• Dangers of propranolol in preterm infants

  2013cited by this paper
• Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing

  2013cited by this paper
• Dramatic Shift in the Infantile Hemangioma Treatment Paradigm at a Single Institution

  2013cited by this paper
• Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study

  2013cited by this paper
• Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?

  2013cited by this paper
• Topical Timolol for Small Hemangiomas of Infancy

  2013cited by this paper
• Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy – a retrospective, single centre study

  2012cited by this paper
• Topical Timolol for Infantile Hemangiomas: Putting a Note of Caution in “Cautiously Optimistic”

  2012cited by this paper
• Propranolol for Infantile Hemangiomas

  2012cited by this paper
• Timolol Maleate 0.5% or 0.1% Gel‐Forming Solution for Infantile Hemangiomas: A Retrospective, Multicenter, Cohort Study

  2012cited by this paper
• Successful Treatment of Infantile Subglottic Hemangioma With Oral Propranolol

  2012cited by this paper
• Efficacy of Propranolol in Hepatic Infantile Hemangiomas with Diffuse Neonatal Hemangiomatosis

  2012cited by this paper
• Nonselective β-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?

  2011cited by this paper
• β-Blockers for Infantile Hemangiomas: A Single-Institution Experience

  2011cited by this paper
• Hepatic Infantile Hemangiomas Treated with Oral Propranolol—A Case Series

  2011cited by this paper
• Treatment of periocular infantile hemangiomas with propranolol: case series of 18 children.

  2011cited by this paper
• Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study

  2011cited by this paper
• Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.

  2011cited by this paper
• Initial Experience With a Multidisciplinary Strategy for Initiation of Propranolol Therapy for Infantile Hemangiomas

  2011cited by this paper
• Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome

  2011cited by this paper
• Propranolol for the Treatment of Orbital Infantile Hemangiomas

  2011cited by this paper
• Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

  2011cited by this paper
• Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.

  2011cited by this paper
• Propranolol for Infantile Hemangiomas

  2011cited by this paper
• A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas.

  2011cited by this paper
• Propranolol for the treatment of subglottic hemangiomas.

  2011cited by this paper
• Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.

  2011cited by this paper
• Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma

  2011cited by this paper
• Management of complicated facial hemangiomas with Beta-blocker (propranolol) therapy.

  2011cited by this paper
• Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.

  2011cited by this paper
• Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma: A Case Report

  2011cited by this paper
• Topical timolol for periocular hemangioma: report of further study.

  2011cited by this paper
• Subglottic and mediastinal hemangioma in a child: treatment with propranolol.

  2011cited by this paper
• Low-dose propranolol for infantile haemangioma.

  2011cited by this paper
• Oral propranolol for treatment of periocular infantile hemangiomas.

  2011cited by this paper
• Preliminary results of propranolol treatment for patients with infantile hemangioma.

  2011cited by this paper
• Topical Treatment for Capillary Hemangioma of the Eyelid Using β-Blocker Solution

  2011cited by this paper
• Propranolol for treatment of ulcerated infantile hemangiomas.

  2011cited by this paper
• Propranolol treatment for subglottic haemangioma

  2011cited by this paper
• A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

  2011cited by this paper
• Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.

  2011cited by this paper
• Successful treatment of infantile haemangiomas of the orbit with propranolol

  2010cited by this paper
• Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas

  2010cited by this paper
• Response of infantile hepatic hemangioma to propranolol resistant to high‐dose methylprednisolone and interferon‐α therapy

  2010cited by this paper
• Massive response of severe infantile hepatic hemangioma to propanolol

  2010cited by this paper
• Propranolol for infantile haemangiomas and neuroglycopenic seizures

  2010cited by this paper
• The use of propranolol in the treatment of periocular infantile haemangiomas: a review

  2010cited by this paper
• Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution.

  2010cited by this paper
• Hepatic haemangioma of infancy: role of propranolol

  2010cited by this paper
• Topical timolol gel for infantile hemangiomas: a pilot study.

  2010cited by this paper
• Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

  2010cited by this paper
• Role of propranolol in the management of periocular hemangiomas.

  2010cited by this paper
• Management of Complicated Facial Hemangiomas with &bgr;-Blocker (Propranolol) Therapy

  2010cited by this paper
• [Infantile hemangioma].

  2010cited by this paper
• Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.

  2010cited by this paper
• Use of propranolol to treat multicentric airway haemangioma

  2010cited by this paper
• Management of infantile subglottic hemangioma: acebutolol or propranolol?

  2010cited by this paper
• Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.

  2010cited by this paper
• Propranolol for isolated orbital infantile hemangioma.

  2010cited by this paper
• Propranolol for orbital hemangioma.

  2010cited by this paper
• Use of propranolol in infantile haemangioma among Chinese children.

  2010cited by this paper
• [Infantile hemangioma. Successful treatment with propranolol].

  2010cited by this paper
• Severe Hypoglycemia During Successful Treatment of Diffuse Hemangiomatosis with Propranolol

  2010cited by this paper
• Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.

  2010cited by this paper
• Propranolol for complicated infantile haemangiomas: a case series of 30 infants

  2010cited by this paper
• Hyperkalemia Complicating Propranolol Treatment of an Infantile Hemangioma

  2010cited by this paper
• Initial experience using propranolol as the sole treatment for infantile airway hemangiomas.

  2010cited by this paper
• Propranolol in the management of periorbital infantile haemangioma

  2010cited by this paper
• Dramatic response of propranolol in hemangioma: report of two cases.

  2010cited by this paper
• Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.

  2010cited by this paper
• Successful treatment of ulcerated haemangioma with propranolol

  2010cited by this paper
• [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].

  2009cited by this paper
• Propranolol for airway hemangiomas: Case report of novel treatment

  2009cited by this paper
• Propranolol for Infantile Hemangiomas: Promise, Peril, Pathogenesis

  2009cited by this paper
• Response of facial haemangioma to oral propranolol

  2009cited by this paper
• Die Propranolol-Therapie in der Behandlung problematischer Hämangiome

  2009cited by this paper
• Successful treatment of isolated subglottic haemangioma with propranolol alone.

  2009cited by this paper
• The safety and efficacy of glaucoma medication in the pediatric population.

  2009cited by this paper
• Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

  2009cited by this paper
• Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

  2009cited by this paper
• Propranolol for severe hemangiomas of infancy.

  2008cited by this paper
• Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.

  2008cited by this paper
• Cardiac and central nervous system toxicity with timolol eye drops in an infant: case report and discussion

  2006cited by this paper
• Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment

  2006cited by this paper
• Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.

  2003cited by this paper
• Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops

  2002cited by this paper
• Second place winner. Absorption of topical ophthalmic medications presenting as lethargy and apnea in an infant.

  2002cited by this paper
• Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE®) once daily versus timolol maleate ophthalmic solution twice daily

  2001cited by this paper
• Systemic Adverse Effects of Ophthalmic β-Blockers

  2001cited by this paper
• Systemic adverse effects of ophthalmic beta-blockers.

  2001cited by this paper
• Systemic side effects of topical beta‐adrenergic blockers

  1996cited by this paper
• Activation of brown adipose tissue thermogenesis in recovery from anesthetic hypothermia in rats.

  1991cited by this paper
• Ophthalmic Topical Beta Blockers: Review of Ocular and Systemic Adverse Effects

  1990cited by this paper
• Clinical experience with timolol in childhood glaucoma.

  1985cited by this paper
• Plasma timolol in glaucoma patients.

  1984cited by this paper
• Thermogenic mechanisms in brown fat.

  1984cited by this paper

• Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial

  2025cites this paper
• Complications of Topical Timolol in the Management of Infantile Hemangiomas: A Systematic Review.

  2025cites this paper
• A retrospective multicenter cohort study of differences in clinical characteristics of Infantile Hemangiomas in preterm and term infants: Prematurity increases risk of permanent cutaneous sequelae.

  2024cites this paper
• Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma

  2024cites this paper
• Oxidized cellulose microneedle patch combined with vascular embolization and local delivery of timolol maleate for hemangiomas.

  2024cites this paper
• The efficacy of extracted Tanshinone compounds for infantile hemangiomas of the skin: results from a pilot study

  2024cites this paper
• IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI)

  2023cites this paper
• Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1.

  2023cites this paper
• Infantile Hämangiome

  2023cites this paper
• Oral topical timolol maleat or oral propranolol treatment for infantile hemangiomas: Clinical analysis of 403 patients

  2023influential citation
• Infantile Hämangiome

  2023cites this paper
• Risk factors of long‐term alopecia after pulsed‐dye laser treatment for infantile scalp hemangiomas: A retrospective study

  2022cites this paper
• News on infantile haemangioma. Part 2: therapy and evaluation

  2021cites this paper
• Drugs Used in Ophthalmology

  2021cites this paper
• Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper

  2021cites this paper
• Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas

  2021cites this paper
• Update on infantile hemangioma Running title: Update on infantile hemangioma

  2021cites this paper
• Modifiable and Nonmodifiable Factors Contributing to Hypothermia Among High Risk Neonates at Admission to NICU—A Prospective Observational Study

  2021cites this paper
• How we approach hemangiomas in infants

  2021cites this paper
• Topical beta‐blockers in dermatologic therapy

  2021cites this paper
• Update on infantile hemangioma

  2021cites this paper
• Off-Label Use and Safety of Drug Use in Vascular Anomalies

  2021cites this paper
• Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.

  2021cites this paper
• Dermatologic Drug Therapy in Children

  2021cites this paper
• An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma

  2020cites this paper
• Vascular Anomalies of the Eyelid and Orbit

  2020cites this paper
• Limited Utility of Repeated Vital Sign Monitoring During Initiation of Oral Propranolol for Complicated Infantile Hemangioma.

  2020cites this paper
• Topical timolol for post-acne erythema.

  2020cites this paper
• Infantile Hemangioma: An Updated Review.

  2020cites this paper
• Traditional and advanced therapeutic modalities for wounds in the paediatric population: an evidence-based review.

  2020cites this paper
• The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta‐analysis

  2020cites this paper
• Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops

  2020influential citation
• Hemangiomen en congenitale vaatmalformaties

  2020cites this paper
• Development of polymeric nanoparticle gel prepared with the combination of ionic pre-gelation and polyelectrolyte complexation as a novel drug delivery of timolol maleate

  2020cites this paper
• The Efficacy and Safety of Topical β-Blockers in Treating Infantile Hemangiomas: A Meta-Analysis Including 11 Randomized Controlled Trials

  2020cites this paper
• Mýty a úskalí v přístupu k pacientovi s infantilním hemangiomem

  2020cites this paper
• Nutzen und Risiken sorgsam abwägen

  2020cites this paper
• Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events

  2020cites this paper
• Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study

  2020cites this paper
• Myths and pitfalls in management of patient with infantile hemangioma

  2020cites this paper
• Current treatment and management of infantile hemangiomas.

  2019cites this paper
• Diagnosis and Management of Infantile Hemangiomas in the Neonate.

  2019cites this paper
• Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases.

  2019cites this paper
• Infantile haemangioma: topical timolol gel may be safer in premature babies.

  2019cites this paper
• Hemangiomas Infantis e Bloqueadores-Beta: 10 Anos Depois da Revolução Terapêutica

  2019cites this paper
• Superficial Genital Infantile Hemangiomas

  2019cites this paper
• Propranolol Accelerats Hemangioma Stem Cell Transformation Into Adipocyte.

  2019influential citation
• FACTORIAL DESIGN AS THE METHOD IN THE OPTIMIZATION OF TIMOLOL MALEATE-LOADED NANOPARTICLE PREPARED BY IONIC GELATION TECHNIQUE

  2019cites this paper
• Topical timolol for superficial cutaneous infantile hemangiomas in very preterm infants

  2019cites this paper
• Infantile Hemangiomas in the Head and Neck Region.

  2018cites this paper
• Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas

  2018influential citation
• Topical propranolol for infantile haemangiomas: a systematic review

  2018cites this paper
• Infantile hemangiomas: An update on pathogenesis, associations, and management

  2018cites this paper
• Clinical Practice Guideline for the Management of Infantile Hemangiomas

  2018cites this paper
• More Than Skin Deep: Lethargy and Diaphoresis in the Morning

  2018cites this paper
• Response to “Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas”

  2018cites this paper
• Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management

  2018cites this paper
• Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial

  2018cites this paper
• Infantile hemangiomas with conjunctival involvement: An underreported occurrence

  2017cites this paper
• Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma.

  2017cites this paper
• Variability of Delivery of Timolol for the Treatment of Infantile Hemangiomas

  2017cites this paper
• Advances in the Medical Management of Vascular Anomalies

  2017cites this paper
• Therapie infantiler Hämangiome

  2017cites this paper
• Infantile Haemangioma: Treatment in a Preterm Infant

  2017cites this paper
• Quality of life in children with infantile hemangioma: a case control study

  2017cites this paper
• Infantile haemangioma and venous malformations: inheritance, risk factors, and treatment safety

  2016cites this paper
• [What's new in pediatric dermatology?]

  2016cites this paper
• Treatment of infantile haemoangioma – Update 2016 Therapie infantiler Hämangiome – Update 2016

  2016cites this paper
• Update December 2016

  2016cites this paper
• LOKALNO LIJEČENJE DOJENAČKIH HEMANGIOMA NESELEKTIVNIM BLOKATORIMA ΒETA ADRENERGIČNIH RECEPTORA U KLINICI ZA DJEČJE BOLESTI U SPLITU OD 2011. DO 2016. GODINE

  2016cites this paper